Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized double-blind placebo-controlled study of SYH2085 tablets for uncomplicated influenza in Chinese adults
CTR20262954Phase 2Active
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SYH2085 in influenza, Influenza A infection, influenza B, sponsored by CSPC ZhongQi Pharmaceutical Technology. Started Sep 2026; status: active.
02
Drugs
SYH2085
03
Conditions
influenzaInfluenza A infectioninfluenza B
Beyond the preview
Go deeper on CTR20262954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262954.